EU Regulators Concerned By Mushrooming Of Small COVID-19 Trials
Want Better Use Of The Short Window Of Opportunity
Based on experience from earlier epidemics, EU regulators are concerned that the high number of COVID-19 trials starting in a confined geography at the peak of the coronavirus pandemic will not be able to enrol patients up to their pre-established sample size.
